Abstract

Abstract Internal mammary chain lymphnodes (IMNs) were studied by lymphoscintigraphy and biopsy in 100 breast cancer patients to assess: (i) if a deep injection can visualize the IMNs in a high percentage of cases (ii) to determine how often IMNs are metastatic. More than 60% of patients showed IMNs uptake. Surgical sampling proved simple and risks insignificant. Five positive IMN cases migrated from NO/N1 to N3, prompting treatment modification. It is unclear whether this additional information can lead to better survival.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.